This inventor holds 4 USPTO granted patents. Top assignee: Oklahoma Medical Research Foundation. Active years: 1998-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tokyo, JP (2001)
- Edmond, OK (US) (1998 - 2007)
Company Filing History:
Years Active: 1998-2007
Title: Innovations by Shinichiro Kurosawa
Introduction
Shinichiro Kurosawa is a notable inventor based in Edmond, OK (US). He has made significant contributions to the field of medical research, particularly in the area of coagulation and anticoagulant therapies. With a total of 4 patents to his name, his work has had a profound impact on the understanding and treatment of hypercoagulable states.
Latest Patents
Kurosawa's latest patents include a method for monitoring coagulability and hypercoagulable states. This involves the assay of soluble endothelial protein C receptor (sEPCR), which is useful for monitoring effective thrombin levels and assessing a hypercoagulable state. The sEPCR ELISA assay is particularly beneficial for tracking the ongoing effectiveness of anticoagulant therapy. Another significant patent involves thrombin binding polypeptides. These small, buffer-soluble polypeptides have amino acid structures that correspond to specific residues of thrombomodulin. They inhibit the clotting activity of thrombin and enhance protein C activation. These polypeptides can be coated onto surfaces that come into contact with mammalian blood, rendering them non-thrombogenic. In pharmaceutical compositions, they serve as a natural anticoagulant.
Career Highlights
Kurosawa is affiliated with the Oklahoma Medical Research Foundation, where he continues to advance his research and innovations. His work has been instrumental in developing new methods and materials that improve patient outcomes in anticoagulant therapy.
Collaborations
Some of his notable coworkers include Deborah J Stearns-Kurosawa and Charles T Esmon. Their collaborative efforts have further enhanced the research and development of innovative solutions in the field of coagulation.
Conclusion
Shinichiro Kurosawa's contributions to medical research through his patents and collaborations highlight his dedication to improving healthcare. His innovative approaches to monitoring and treating coagulation disorders continue to influence the field significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile